General Information
Version
4.0
Revision date
2024-10-04
Product name
Chelal Kubig
Icons in SDS
Company Information
company name
BMS Micro-Nutrients NV
e-mail address of the competent person responsible for the Safety Data Sheet
info@chelal.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H315, H317, H318, H411
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Harmful if swallowed. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage. Toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07 GHS09
Signal word
Danger
Contains
Reaction products of amines, polyethylenepoly-, triethylenetetramine fraction and copper sulphate (1:1) ; Reaction products of 2,2'-iminodi(ethylamine) and copper sulphate (1:1).
Hazard statements
H302 - Harmful if swallowed. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H411 - Toxic to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P391 - Collect spillage.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %